Syndax sees operating expense base remaining stable over next few years

For FY25, the company expects total research and development plus selling, general and administrative expenses to be $380M-$385M, compared to prior guidance of $370M-$390M, both estimates excluding an estimated $45M in non-cash stock compensation expense. Syndax (SNDX) expects that its operating expense base will remain stable over the next few years. As a result, Syndax expects that its cash, cash equivalents and short- and long-term investments, combined with its anticipated product revenue and interest income, will enable the company to reach profitability.